Overall, these findings suggest that high IF1 levels in breast carcinomas in some way correlate with a decrease of metastasis despite supporting a pro-oncogenic metabolic phenotype (21, 22, 27). The gene discussed is ATP5IF1; the disease is breast carcinoma.